Prime Bio, Inc. Announced Patent Award for Vaccine Technology using Tetanus Vaccine Platform in USA & South Africa

Press Release on : 12-Nov-2024

Prime Bio, Inc. (PBI) Announces Patent Award for Vaccine Technology using Tetanus Vaccine Platform in the USA  (Application No. 18/060,401) and South Africa (PA180053/ZA)